Related Experiment Video
Updated: Jul 18, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and
1State University of New York School of Medicine, Stony Brook, NY, USA.
Abstract:
Antibiotic resistance among pneumococci, enterococci, and staphylococci has become increasingly important in recent decades. Clinicians should be familiar with the nuances of antibiotic susceptibility testing and interpretation in selecting antibiotics for these infections. The clinical significance of penicillin-resistant Streptococcus pneumoniae, macrolide-resistant S pneumoniae, and multidrug-resistant S pneumoniae is discussed. The clinical spectrum and therapeutic approach to Enterococcus faecalis (i.e., vancomycin-sensitive enterococci) and E faecium (i.e., vancomycin-resistant enterococci) are discussed. Differences in therapeutic approach between methicillin-sensitive Staphylococcus aureus and methicillin-resistant S aureus (MRSA) infections are reviewed. Differences between in vitro susceptibility testing and in vivo effectiveness of antibiotics for hospital-acquired MRSA (HA-MRSA) are described. Finally, the clinical features of infection and therapy of HA-MRSA and community-acquired MRSA (CA-MRSA) infections are compared.
Insights
Antibiotic resistance in Streptococcus pneumoniae, Enterococcus, and Staphylococcus is a growing concern. Understanding antibiotic susceptibility testing is crucial for effective treatment of these resistant bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Rising antibiotic resistance in key bacterial pathogens like Streptococcus pneumoniae, Enterococcus, and Staphylococcus presents significant clinical challenges.
- The increasing prevalence of multidrug-resistant strains necessitates a thorough understanding of antimicrobial susceptibility patterns.
Purpose of the Study:
- To review the clinical significance of antibiotic resistance in Streptococcus pneumoniae, including penicillin, macrolide, and multidrug resistance.
- To discuss the therapeutic approaches for Enterococcus faecalis (vancomycin-sensitive enterococci) and Enterococcus faecium (vancomycin-resistant enterococci).
- To compare treatment strategies for methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) infections, including hospital-acquired (HA-MRSA) and community-acquired (CA-MRSA) strains.
Main Methods:
- Literature review and synthesis of current clinical guidelines and research.
- Analysis of antibiotic susceptibility testing principles and interpretation.
- Comparative review of therapeutic options for specific resistant bacterial infections.
Main Results:
- Penicillin-resistant, macrolide-resistant, and multidrug-resistant Streptococcus pneumoniae strains pose distinct clinical challenges.
- Distinct therapeutic strategies are required for vancomycin-sensitive Enterococcus faecalis versus vancomycin-resistant Enterococcus faecium.
- Differences in treatment exist between MSSA and MRSA, with specific considerations for HA-MRSA and CA-MRSA.
Conclusions:
- Effective management of infections caused by resistant pneumococci, enterococci, and staphylococci hinges on accurate antibiotic susceptibility testing and tailored therapeutic choices.
- Clinicians must be adept at interpreting susceptibility data to optimize antibiotic selection for these challenging pathogens.
- Understanding the nuances between in vitro susceptibility and in vivo efficacy, particularly for MRSA, is critical for successful patient outcomes.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness